Cannabis, Cannabinoids & Psychedelics
New Uses for Old Drugs
Did you know cannabis has been used in the treatment of spasticity in Multiple Sclerosis. Cannabis is also well-known for its benefit as a chronic pain relief. Canada has recently legalized the use of medical cannabis.
Ketamine, MDMA (ecstasy) and psilocybin, commonly known as magic mushrooms, have the potential to treat depression, anxiety, PTSD and addiction. In the United States, the Federal Drug Administration (FDA) has granted psilocybin and MDMA ‘breakthrough therapy’ status for depression and PTSD respectively.
We need new treatments, and we need to employ sound scientific principles to this emerging new field, so we best know how to move forward
Dr. Valerie Taylor
Research Highlights
Parker Chair in Psychedelics
Generous Calgarian, Jim Parker, steps forward to support research focusing on treatments for mental illness.
Cannabis DYK?
Integrating research into the community is our way of empowering you for better outcomes in mental health.
UCalgary and Enveric Biosciences collaborate on clinical trial for EVM-101
Clinical trial aim is to include the identification and characterization of the Cancer Related Distress symptoms most responsive to psychedelic-associated therapy.